Important Information

AMP 2013 Annual Meeting
November 14-16, 2013
Phoenix Convention Center
Phoenix, AZ
Corporate Workshop Day
November 13, 2013
Visit Meeting Page

AMP 2013 MGP Review Course
April 4-7, 2013
Double Tree by Hilton Hotel
Bethesda - Washington DC
Visit Course Page

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP
Volunteer

more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters

AMP Position statements and letters

AMP Position Statements and Letters - 2009

2009	Title	Keywords	Committee

November	Letter to HHS Office for Civil Rights to support amending HIPAA Privacy Rule to implement GINA		Professional Relations
	AMP urges federal agencies to implement GINA		Professional Relations

October	AMP reiterates its position on gene patents, direct-to-consumer marketing of genetic testing, and genetic nondiscrimination to the Secretary's Advisory Committee on Genetics, Health & Society (SACGHS) on October 8		Professional Relations
	AMP lobbies for equitable reimbursement - AMP has been vigorously advocating with members of Congress for several months to revise or reject legislation that would eliminate the 14-day waiting period for a wide spectrum of molecular tests - for laboratories that are independent of the hospital where the specimen was collected and not under any arrangements.		Economic Affairs

September	Comments to CLIAC regarding ensuring laboratory testing quality during a public health emergency: AMP labs during the Spring 2009 H1N1 outbreak		Professional Relations
	Comments to NIST Roadmap: "Measurement Science and Measurement Standards to Support Innovation in Healthcare		Professional Relations
	Comments to AHRQ Draft Report on LDTs		Clinical Practice

August	Letter to Dr. Janet Woodcock encourages FDA to always identify a companion diagnostic on drug labeling by the biological description		Clinical Practice

June	AMP comments to the SACGHS		Professional Relations
	AMP priorities for Comparative Effectiveness Research (CER)		Professional Relations
	AMP Principles for Health Care Reform		Professional Relations
	Comments to House Science & Technology Committee regarding the immediate and long-term needs for standards development in biotechnology at NIST		Clinical Practice

May	AMP comments to the SACGHS draft report on gene patents		Professional Relations
	MEDCAC Comments		Economic Affairs

April	AMP responds to Genentech Citizen Petition		Professional Relations
	AMP responds to Genentech Citizen Petition		Clinical Practice

March	AMP recommends to the IOM priorities for Stimulus Bill spending on comparative effectiveness research (CER)		Professional Relations

Feburary	Comments to NHGRI Regarding Long Range Planning		Clinical Practice
	AMP Position on Genetic Ancestry Testing		Clinical Practice
	MEDCAC Presentation		Economic Affairs

January	Comments on ACMG's Technical Standards and Guidelines for Myotonic Dystrophy Type 1 Testing		Clinical Practice
	MEDCAC/CMS Letter		Economic Affairs